BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Prosidion Limited Pages on BioPortfolio:

BioPortfolio - Prosidion Ltd
Prosidion Ltd - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/28722-Prosidion+Ltd...

BioPortfolio - BioPortfolio - Prosidion Ltd
BioPortfolio - Prosidion Ltd - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/28722/www.p...

BioPortfolio - Prosidion Ltd - Profile
Limited, in Oxford, UK. Recent Publications by Prosidion Ltd: • 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine
in ...
http://www.bioportfolio.com/biocorporate/28722-Prosidion+Ltd...

BioPortfolio - Prosidion Ltd patents
Prosidion Ltd patents - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/28722-Prosidion+Ltd...

BioPortfolio News: Dvc - DVC Deutsche Venture Capital achieves a...
DVC Deutsche Venture Capital achieves a substantial return on the asset sale of portfolio company Probiodrug to Prosidion Ltd. ...
http://www.bioportfolio.com/news/DVC_Deutsche_Venture_Capita...

BioEmail – Email lists for specifically targeting professionals ...
Prosidion Ltd, Watlington Road, Oxford. • Prolysis Ltd., Begbroke Science Park, Sandy Lane, Yarnton Oxfordshire. • Oxford Biosensors Limited, Oxford ...
http://www.bioportfolio.com/pdf/fermentors.pdf...

BioPortfolio - Dvc - Life Sciences Day of DVC Deutsche Venture ...
1 Jul 2004 ... UK biotech company Prosidion Ltd. Interesting insights into the biotech area in Germany and Europe from the perspective of academia, ...
http://www.bioportfolio.com/news/Life_Sciences_Day_of_DVC_De...

BioPortfolio - the biotechnology, pharmaceutical, life science and ...
Findings from BioNgene Co., Ltd. in drug resistance reported NewsRX Sep 10 2009 ... prosidion limited | ids ltd | huntingdon life sciences labs | Prostrakan ...
http://www.bioportfolio.com/bookshop/search/Blood/...

BioPortfolio News: Dvc - Life Sciences Day of DVC Deutsche...
... announced a planned IPO on the Frankfurt Stock Exchange and Probiodrug elaborated on the $ 35 million deal with the UK biotech company Prosidion Ltd.
...
http://www.bioportfolio.com/news/Life_Sciences_Day_of_DVC_De...

BioPortfolio - Probiodrug AG
DVC Deutsche Venture Capital achieves a substantial return on the asset sale of portfolio company Probiodrug to Prosidion Ltd. 9th July 2004 Munich – DVC ...
http://www.bioportfolio.com/biocorporate/28650-Probiodrug_AG...

Results from other life science and pharmaceutical sites:

Shaping Medicine, Changing Lives
OSI Pharmaceuticals is committed to "shaping medicine and changing lives" by discovering, developing and commercializing high-quality, ...
http://www.osip.com/...

OSI Pharmaceuticals, Inc. - Google Finance
OSI also has research and development programs in diabetes and obesity, which are conducted through Prosidion Limited, the Company's United Kingdom ...
http://www.google.com/finance?q=NASDAQ:OSIP...

Anker Lundemose, M.D., Ph. D.
He was appointed Executive VP, OSI Pharmaceuticals, Inc. and President, (OSI) Prosidion, in March 2005 having been the CEO of Prosidion Limited since the ...
http://www.osip.com/mgmt_lundemose...

PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 ...
We thank the following for their contributions to this work: J Bloxham, JG Mc Cormack, M Procter and PS Widdowson (Prosidion Limited). ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21...

Privacy Policy
OSI Pharmaceuticals, Inc. has nominated representatives in the EU, OSI Pharmaceuticals (UK) Limited and Prosidion Limited, for the purposes of data ...
http://www.osip.com/privacy...

5-HT(1A) activation counteracts cardiovascular but not hypophagic ...
Prosidion Research, Prosidion Limited, Oxford, UK. gthomas@prosidon.com. The noradrenaline (NA) and serotonin reuptake inhibitor, sibutramine, ...
http://www.ncbi.nlm.nih.gov/pubmed/19219064...

Diabetes & Obesity
OSI's diabetes and obesity R & D programs are conducted through Prosidion Limited, our wholly-owned U.K. subsidiary. Our core competencies comprise ...
http://www.osip.com/scires_diabetes_obesity...

Obesity - Abstract of article: 5-HT1A Activation Counteracts ...
1Prosidion Research, Prosidion Limited, Oxford, UK; 2Cerep S.A., Rueil-Malmaison , France; 3Present address: Oxford BioMedica, Medawar Centre, Oxford Science ...
http://www.nature.com/oby/journal/v17/n3/abs/oby2008550a.htm...

Genentech: Newsroom: Press Releases: News Release May 2, 2005
2 May 2005 ... Company has a second business interest in the area of diabetes through its subsidiary, Prosidion Limited, based in the United Kingdom. ...
http://www.gene.com/gene/news/press-releases/display.do?meth...

Modulation of extracellular matrix genes reflects the magnitude of ...
6OSI Prosidion Ltd, Oxfordshire, OX4 6LT, UK. Corresponding author. James A Timmons: Jamie.Timmons/at/cgb.ki.se; Eva Jansson: Eva.Jansson/at/labtech.ki.se;
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224855/...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.